Tianjin TEDA Biomedical Engineering Dividends and Buybacks
Dividend criteria checks 0/6
Tianjin TEDA Biomedical Engineering does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected
Dec 02
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump
Oct 17There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump
Aug 16Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk
May 07Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?
Sep 12Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding
Apr 17Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?
Apr 07Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Nov 01Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt
Apr 21Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?
Oct 26Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?
Apr 06Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Dec 22
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 8189's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 8189's dividend payments have been increasing.
Dividend Yield vs Market
| Tianjin TEDA Biomedical Engineering Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (8189) | n/a |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Chemicals) | 5.1% |
| Analyst forecast (8189) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 8189's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 8189's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 8189's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 8189 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 13:31 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin TEDA Biomedical Engineering Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|